Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Solid Biosciences
(NASDAQ:SLDB)
Intraday
$9.04
0.50
[5.85%]
After-Hours
$9.04
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$9.04
0.50
[5.85%]
At close: Apr 22
$9.04
0
[0.00%]
PreMarket: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Solid Biosciences Stock (NASDAQ:SLDB)
Solid Biosciences Stock (NASDAQ: SLDB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 02, 2024
Solid Biosciences shares are trading higher after the company received Rare Pediatric Disease Designation for SGT-003 from the FDA.
Benzinga Newsdesk
-
Apr 2, 2024, 8:44AM
Monday, April 01, 2024
Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
Benzinga Newsdesk
-
Apr 1, 2024, 7:48AM
Thursday, March 28, 2024
William Blair Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $40
Benzinga Newsdesk
-
Mar 28, 2024, 10:42AM
Monday, March 18, 2024
Barclays Maintains Overweight on Solid Biosciences, Raises Price Target to $21
Benzinga Newsdesk
-
Mar 18, 2024, 6:25AM
Friday, March 15, 2024
Citigroup Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $16
Benzinga Newsdesk
-
Mar 15, 2024, 10:56AM
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Mar 15, 2024, 10:25AM
Thursday, March 14, 2024
Solid Biosciences shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $8 to $20.
Benzinga Newsdesk
-
Mar 14, 2024, 8:59AM
HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $16 Price Target
Benzinga Newsdesk
-
Mar 14, 2024, 7:30AM
Piper Sandler Upgrades Solid Biosciences to Overweight, Raises Price Target to $20
Benzinga Newsdesk
-
Mar 14, 2024, 4:57AM
Wednesday, March 13, 2024
Solid Biosciences Said Entered Into Non-exclusive Licensing Agreement For Use Of Its Proprietary, Muscle-targeted AAV-SLB101 Capsid
Charles Gross
-
Mar 13, 2024, 7:51AM
Solid Biosciences Q4 2023 Net Loss Of $(20.3)M Compared To $(15.2)M YoY, With Cash Balance Of $123.6M Which Is Expected To Provide Cash Runway Into 2026
Benzinga Newsdesk
-
Mar 13, 2024, 7:49AM
Friday, March 08, 2024
Solid Biosciences shares are trading higher. The company on Thursday announced a licensing agreement with Armatus Bio for the use of AAV-SLB101.
Benzinga Newsdesk
-
Mar 8, 2024, 12:57PM
Thursday, March 07, 2024
Solid Biosciences Announces Licensing Agreement With Armatus Bio For The Use Of AAV-SLB101, A Proprietary, Muscle-targeted Capsid, In The Development Of An RNAi Therapy To Treat FSHD
Benzinga Newsdesk
-
Mar 7, 2024, 7:07AM
Monday, February 26, 2024
5 Value Stocks In The Healthcare Sector
Benzinga Insights
-
Feb 26, 2024, 9:44AM
Thursday, February 15, 2024
Top 4 Health Care Stocks You May Want To Dump In February
Avi Kapoor
-
Feb 15, 2024, 8:15AM
Monday, February 05, 2024
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
-
Feb 5, 2024, 9:44AM
Thursday, February 01, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Feb 1, 2024, 12:31PM
Wednesday, January 31, 2024
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 31, 2024, 1:18PM
Tuesday, January 30, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Jan 30, 2024, 4:31PM
Tuesday, January 16, 2024
Solid Biosciences Granted FDA Orphan Drug Designation For Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003; Patient Dosing Expected To Begin Mid-To-Late Q1 2024
Benzinga Newsdesk
-
Jan 16, 2024, 8:08AM
Insiders Buying Solid Biosciences And 2 Other Stocks
Avi Kapoor
-
Jan 16, 2024, 6:17AM
Tuesday, January 09, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 9, 2024, 12:31PM
Monday, January 08, 2024
Solid Biosciences Shares Halted On Circuit Breaker To The Upside, Stock Now Up 56.4%
Benzinga Newsdesk
-
Jan 8, 2024, 9:49AM
Solid Biosciences Announces $109M Private Placement Selling $16.97M Shares to Fund Ongoing Pipeline Development Programs
Benzinga Newsdesk
-
Jan 8, 2024, 7:20AM
Monday, January 01, 2024
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
-
Jan 1, 2024, 9:43AM
Friday, December 08, 2023
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Dec 8, 2023, 12:57PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Dec 8, 2023, 8:07AM
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Dec 8, 2023, 8:05AM
HC Wainwright & Co. Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $9
Benzinga Newsdesk
-
Dec 8, 2023, 6:43AM
Thursday, December 07, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 7, 2023, 4:31PM
What's Going On With Solid Biosciences Stock Today?
Ryan Gustafson
-
Dec 7, 2023, 4:05PM
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Dec 7, 2023, 1:13PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Dec 7, 2023, 12:31PM
Solid Biosciences Receives FDA Fast Track Designation For Its SGT-003 Duchenne Muscular Dystrophy Gene Therapy Candidate
Benzinga Newsdesk
-
Dec 7, 2023, 8:02AM
Friday, November 17, 2023
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Nov 17, 2023, 1:01PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Nov 17, 2023, 12:31PM
Wednesday, November 15, 2023
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Nov 15, 2023, 2:04PM
Why Solid Biosciences Stock Is Climbing Today
Erica Kollmann
-
Nov 15, 2023, 12:01PM
Market-Moving News for November 15th
Benzinga Newsdesk
-
Nov 15, 2023, 8:48AM
Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 15, 2023, 8:07AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 15, 2023, 8:06AM
Solid Biosciences shares are trading higher after the FDA cleared the company's IND for Duchenne muscular dystrophy gene therapy candidate.
Benzinga Newsdesk
-
Nov 15, 2023, 7:01AM
Tuesday, November 14, 2023
Solid Biosciences Announces IND Clearance By FDA For Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
Benzinga Newsdesk
-
Nov 14, 2023, 4:39PM
Thursday, November 09, 2023
Solid Biosciences shares are trading lower. The company reported Q3 financial results.
Benzinga Newsdesk
-
Nov 9, 2023, 2:09PM
Wednesday, November 08, 2023
Solid Biosciences Q3 EPS $(1.05) Beats $(1.19) Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 5:36PM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 2, 2023, 1:00PM
Solid Biosciences Appoints Gabriel Brooks, As Chief Medical Officer
Benzinga Newsdesk
-
Oct 2, 2023, 8:06AM
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 28, 2023, 2:32PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch